Canadian Online Pharmacy

CDER New February 10, 2014

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

February 7, 2014 


New and Generic Drug Approvals

February 6, 2014

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Aloxi palonosetron hydrochloride Injectable;Intravenous Helsinn Hlthcare Labeling Revision
Anadrol-50 oxymetholone Tablet;Oral Meda Pharms Manufacturing Change or Addition
Aripiprazole aripiprazole Tablet; Oral Apotex Inc Tentative Approval
Buprenex buprenorphine hydrochloride Injectable;Injection Reckitt Benckiser Manufacturing Change or Addition
Cisplatin cisplatin Injectable;Injection Hq Spclt Pharma Manufacturing Change or Addition
Imuran azathioprine Tablet;Oral Prometheus Labs Labeling Revision
Imuran azathioprine sodium Injectable;Injection Prometheus Labs Labeling Revision
Platinol cisplatin Injectable;Injection Hq Spclt Pharma Manufacturing Change or Addition
Platinol-Aq cisplatin Injectable;Injection Hq Spclt Pharma Manufacturing Change or Addition
Pramipexole Dihydrochloride pramipexole dihydrochloride Tablet, Extended Release;Oral Anchen Pharms Approval
Zelboraf vemurafenib Tablet;Oral Hoffmann La Roche Labeling Revision

 


This email was sent to kostikblog@ukr.net using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery